A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman, A. L. & Tainsky, M. A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene27, 5975–5987 (2008). source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher, L. A. et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol. Med.2, 458–471 (2010). sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl, L. et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod. Pathol.24, 1015–1022 (2011). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke, M. et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell18, 135–146 (2010). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell21, 105–120 (2012). sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso, M. et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv.454, 291–302 (2009). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,501–1,600 of 2,273
Chen, Y., Zhou, T., Zhou, R., Sun, W. C., Li, Y., Zhou, Q., Xu, D., Zhao, Y., Hu, P., Liang, J., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03363-1 · Cited by 12
Liu, S., Zheng, Y., Cui, B., Yang, J., Yuan, B., Cao, Y., Zhao, Z., Sun, Z., Wang, Q., Yang, X., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123709 · Cited by 9
Hu, J., Yu, D., Wang, J., Guo, P., Chen, M., Wu, D., Cai, Y., Wang, Y., Ji, J., Yao, X., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417708122 · Cited by 12
“Consistent with this, we find that cultured OA synovial organoids exhibited increased expression of IL1 α [a key component of the “IL1 family signaling” and SASP factors during cellular senescence ( 32 , 33 )] and p16 (a classical marker of SNCs) compared with the non - OA group ( Fig.”
Wang, D., & Guan, H. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156115 · Cited by 9
Niazi, S. K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123904 · Cited by 8
Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer
Meguro, S., Makabe, S., Yaginuma, K., Onagi, A., Tanji, R., Matsuoka, K., Hoshi, S., Koguchi, T., Kayama, E., Hata, J., et al. (2025) · Current Oncology · doi:10.3390/curroncol32080467 · Cited by 9
“Moreover, the SASP induces senescence in neighboring non-senescent cells in a paracrine manner [28].”
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.010 · Cited by 10
“TGF-ß affects senescent cells both autocrinally and paracrinally, and together with VEGF, it can induce cellular senescence in the surrounding normal cells in vitro (called paracrine senescence) 124 .”
Guo, C., Li, X., Fan, Z., Zhang, J., & Chen, M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561232 · Cited by 13
“Senescent cells release a series of SASP factors, which accumulate in large amounts within these cells and can further enhance senescence signaling through autocrine mechanisms [99,101].”
Review: Systemic inflammation after stroke. Therapy and perspective
Abuzan, M., Cercel, A., Doeppner, T. R., Hermann, D. M., Surugiu, R., Pîrșcoveanu, D. F. V., & Popa‐Wagner, A. (2026) · GeroScience · doi:10.1007/s11357-025-02070-1 · Cited by 11
“In senescent cells, the inflammasome and IL-1 signaling pathways are activated, and IL-1α expression alone can induce SASP activation, reinforcing the senescent state [21].”
Mastoridou, E. M., GOUSSIA, A. C., Kataki, A., Koniaris, E., Glantzounis, G. K., Papoudou‐Bai, A., Kanavaros, P., & Charchanti, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021066 · Cited by 11
“During this phase, inflammatory SASP-associated factors, such as IL-1, can be detected at very low levels in the extracellular milieu [20].”
InfluentialElectrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability
D’Ambrosio, M., White, M. E. H., Gavriil, E.-S., Bousset, L., Birch, J., Gruevska, A., Pasquini, E., Colucci, M., Fong, W., Mosole, S., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01921-z · Cited by 17
Self-citationStorozynsky, Q. T., Han, X., Komant, S. J., Agopsowicz, K. C., Potts, K. G., Gamper, A. M., Godbout, R., Evans, D. H., & Hitt, M. (2023) · Cancers · doi:10.3390/cancers15133341 · Cited by 9
“NF-κB is a master regulator of the SASP, and SASP factors can reinforce senescence in an autocrine manner while also inducing the senescence of adjacent cells in a paracrine manner [59,96,97].”
BackgroundOtani, Y., Nozaki, Y., Mizunoe, Y., Kobayashi, M., & Higami, Y. (2023) · Pathology International · doi:10.1111/pin.13371 · Cited by 9
“…colleagues reported that understanding the importance and regulation of paracrine senescence will provide a new avenue for therapeutic bene fi t. 71,72 Recently, senescent cells are shown to accumulate in aged individuals, while their removal improves age ‐ related pathologies and extends lifespan.”
BackgroundAlsalem, M., Ellaithy, A., Bloukh, S., Haddad, M., & Saleh, T. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-023-08287-0 · Cited by 13
“…[17]), apoptosis resistance [18], epigenetic modulations [19], and, most importantly, vast alterations in gene and protein expression leading to the secretion of a plethora of soluble and insoluble proteins to the microenvironment termed the senescence-associated secretory phenotype (SASP) [20–23].”
IGF2BP3/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability
Li, Y., Luo, C., Cai, Y., Wu, Y., Shu, T., Wei, J., Wang, H., & Niu, H. (2024) · Translational research · doi:10.1016/j.trsl.2024.06.004 · Cited by 9
Alterations of receptors and insulin-like growth factor binding proteins in senescent cells
Matuszewska, J., Krawiec, A., Radziemski, A., Uruski, P., Tykarski, A., Mikuła‐Pietrasik, J., & Książek, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151438 · Cited by 8
Caruso, J. A., Chen‐Tanyolac, C., & Tlsty, T. D. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01920-8 · Cited by 13
Li, T., Li, L., Li, F., & Liu, Y. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.028 · Cited by 10
Senescence suppressed proliferation of host hepatocytes is precondition for liver repopulation
Chen, J., Yang, T., Song, S., Liu, Q., Sun, Y., Zhao, L., Fu, Z., Wang, M., Hu, Y., & Chen, F. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.103 · Cited by 8
Human innate immune cell crosstalk induces melanoma cell senescence
Funck, F., Pahl, J. H. W., Kyjacová, L., Freund, L., Oehrl, S., Gräbe, G., Pezer, S., Hassel, J. C., Sleeman, J. P., Cerwenka, A., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1808424 · Cited by 9
“This cell-intrinsic mechanism is propagated by SASP-mediated release of factors triggering senescence in neighboring cells.(41) Moreover, chemotactic SASP factors recruit innate immune cells supporting the clearance of senescent tumor cells(42) and increased secretion of inflammatory mediators such as IL-1β potentiall…”
BackgroundMorris, C., Durand, S., & Jalinot, P. (2021) · Oncotarget · doi:10.18632/oncotarget.27923 · Cited by 8
“Secreted SASP factors, mainly pro-inflammatory cytokines and chemokines, operate as diffusible signals that reinforce and propagate senescence in autocrine and paracrine fashions [40, 41].”
BackgroundWada, Y., Umeno, R., Nagasu, H., Kondo, M., Tokuyama, A., Kadoya, H., Kidokoro, K., Taniguchi, S., Takahashi, M., Sasaki, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179269 · Cited by 9
Franceschi, C., Capri, M., Garagnani, P., Ostan, R., Santoro, A., Monti, D., & Salvioli, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_45-1 · Cited by 11
Zhao, M., Pan, B., He, Y., Niu, B., & Gao, X. (2022) · Aging · doi:10.18632/aging.204185 · Cited by 11
Goodenough, C. G., Wogksch, M. D., Kundu, M., Lear, M., Thomas, P. G., Srivastava, D. K., Wang, Z., Armstrong, G. T., Hudson, M. M., Robison, L. L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1014661 · Cited by 8
Wang, X., Huang, Z., Li, L., Yang, Y., Zhang, J., Wang, L., Yuan, J., & Li, Y. (2022) · Genes · doi:10.3390/genes14010039 · Cited by 10
“Changes in the expression of splicing factors are found in 50% of age-associated alternative splicing [1].”
BackgroundInfluentialThe Possible Role of Β-Cell Senescence in the Development of Type 2 Diabetes Mellitus
Novoselova, E. G., Lunin, S. M., Khrenov, M. O., Glushkova, O. V., Novoselova, T. V., & Parfenyuk, S. B. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000606 · Cited by 14
Richter, E., Lohmann, C. H., Dell’Accio, F., Goettsch, C., & Bertrand, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512343 · Cited by 8
Erdheim-Chester disease: from palliative care to targeted treatment
Graziani, G., Podestà, M. A., Cucchiari, D., Reggiani, F., & Ponticelli, C. E. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu068 · Cited by 8
“senescence-associated secretory phenotype [23, 24].”
Senescent Cells Drive Frailty through Systemic Signals
Lehmann, J., Baar, M. P., & de Keizer, P. L. J. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.003 · Cited by 9
Bianchi, A., Lipchick, B. C., & Nikiforov, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_1 · Cited by 10
“Classically, the SASP is identified through ELISA or qRT-PCR assay for some of its major components; however, more recently a novel approach based on widefield high-content microscopy has been reported (90).”
BackgroundFuturistic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis
Jha, L. A., Kumar, B., Jha, S. K., & Paudel, K. R. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0348 · Cited by 9
Tilman, G., Dupré, E., Watteyne, L., Baert, C. A., Nolf, D., Benhaddi, F., Lambert, F., Daumerie, A., Bouzin, C., Lucas, S., et al. (2023) · Lupus Science & Medicine · doi:10.1136/lupus-2023-001010 · Cited by 11
Network of extracellular vesicles surrounding senescent cells
Okawa, H., Tanaka, Y., & Takahashi, A. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109953 · Cited by 8
Data‐ and theory‐driven approaches for understanding paths of epithelial–mesenchymal transition
Hong, T., & Xing, J. (2024) · genesis · doi:10.1002/dvg.23591 · Cited by 7
“…expressions and function reprogramming, such as the context-dependent coupling between EMT programs and stemness regulation programs, as exam-pled by a few existing such studies (Acosta et al., 2013; Bocci et al., 2021; Hari et al., 2022; Hari et al., 2023; Hu et al., 2023; Watanabe et al., 2019).”
BackgroundMechanisms and metabolic consequences of adipocyte progenitor replicative senescence
Lin, T., Mohammad, A., Kolonin, M. G., & Eckel‐Mahan, K. L. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000046 · Cited by 10
“Senescent cells, which release cytokines such as IL6, IL8, and TNF α , can influence neighboring non-senescent cells to also adopt a senescent phenotype [83] .”
BackgroundNong, C., Wu, Z., Yang, C., Xü, W., Luo, L., Zhou, J., Shen, L., Chen, Y., Yuan, Y., & Hu, G. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1449423 · Cited by 8
Alpha synuclein and inflammaging
Putnam, G. L., & Maitta, R. W. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41981 · Cited by 8
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue
Khasawneh, A. I., Shboul, S. A., Himsawi, N. M., Rousan, A. A., Shahin, N. A., El‐Sadoni, M., Alhesa, A., Ghalioun, A. A., Khawaldeh, S., Shawish, B., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13499-0 · Cited by 8
“However, OIS has been described to have a double-edged sword effect on tumor progression largely due to its effect on the tumor environment mediated by the Senescence-associated Secretory Phenotype (SASP) [17, 18].”
Oh, S. J., Kim, Y. H., Kim, B. R., Seo, H., Kwon, S., Choi, H., Lee, H., Na, J., Choi, C. P., Ko, J. Y., et al. (2025) · Annals of Dermatology · doi:10.5021/ad.24.167 · Cited by 9
p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics
Niklasson, M., Dalmo, E., Segerman, A., Rendo, V., & Westermark, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093974 · Cited by 12
“Senescence can be induced by various factors, including telomere shortening, oncogene activation, radiation, oxidative stress, chemotherapy, cell enlargement, and cytokine signaling [17–24].”
Cheng, S.-Y., Koppitch, K. A., Guo, J., Moy, N., Simonian, T. L., Wilson, P. C., & McMahon, A. P. (2025) · Kidney360 · doi:10.34067/kid.0000000868 · Cited by 8
“44,59 Genetic studies using a dominant negative strategy to broadly antagonize NF-k B – associated transcriptional activity in renal tubules demonstrated reduced tubular injury on AKI and attenuated in fl ammatory-associated fi brosis.”
Almudimeegh, S., Almutairi, M. M., Softah, A., Alhazzani, K., Binobaid, L., Alshammari, M. A., Sobeai, H. M. A., Saleh, T., Alotaibi, M. R., & Alhoshani, A. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00034-2 · Cited by 10
“Venetoclax, by selectively inhibiting BCL-2, disrupts this feedback loop and promotes apoptosis(Wang, et al. 2020; Diamantidis et al. (Acosta et al. 2013; Freund et al. 2011; Kojima et al. 2013; Ortiz-Montero et al. 2017; Mosteiro, et al. 2018).”
Pursuing healthy aging and longevity through natural product and stem cell-driven rejuvenation
Wu, D., Xu, Q., Wu, S., Tan, J., Khan, F. A., Pandupuspitasari, N. S., & Huang, C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117359 · Cited by 11
Tian, M., Ma, J., Li, Z., Ye, C., Cui, X., Wang, G., Liu, S., Qudus, M. S., Afaq, U., Fan, H. M., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02466-8 · Cited by 8
Gao, P., Cenatus, S., Henley, N., Pichette, V., Mallette, F. A., Barrera‐Chimal, J., & Gerarduzzi, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08268-7 · Cited by 11
Integrating Senescence and Oxidative Stress in Cardiac Disease
Yun, H. R., Singh, M. K., Han, S., Ranbhise, J. S., Ha, J., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411917 · Cited by 8
“…human fibroblasts, senescent cells elucidate a characteristic secretory program [3], the senescence-associated secretory phenotype (SASP), which comprises cytokines, chemokines, growth factors, matrix-remodeling enzymes, and other mediators that act via autocrine and paracrine signaling [4,5].”
Bibliometric and visualization analysis of global research trends on immunosenescence (1970–2021)
Tan, Y., Zhang, C., Li, D., Huang, J., Liu, Z., Chen, T., Zou, X., & Qin, B. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112089 · Cited by 6
“In addition, SASP promotes cellular senescence in a paracrine manner, promoting senescence in surrounding cells that have no aging characteristics (35-37).”
BackgroundRecent Advancement in Elimination Strategies and Potential Rejuvenation Targets of Senescence
Kureel, S. K., Blair, B., & Sheetz, M. P. (2023) · Advanced Biology · doi:10.1002/adbi.202300461 · Cited by 10
Decellularized diseased tissues: current state‐of‐the‐art and future directions
Li, X., Shan, J., Chen, X., Cui, H., Wen, G., & Yu, Y. (2023) · MedComm · doi:10.1002/mco2.399 · Cited by 8
“161,162 Furthermore, TGF-β 1 can inhibit the antifibrosis immunity of the liver by regulating the differentiation of regulatory T cells.”
BackgroundCellular senescence in age-related musculoskeletal diseases
Xiong, J., Guo, Q., & Luo, X. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1125-7 · Cited by 10
Panahipour, L., Kargarpour, Z., Laggner, M., Mildner, M., Ankersmit, H. J., & Gruber, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228569 · Cited by 8
“This mechanism of controlling local osteoclastogenesis is not restricted to osteocytes as also senescent fibroblasts can drive the process of osteoclastogenesis [8].”
BackgroundTargeting the stress support network regulated by autophagy and senescence for cancer treatment
Kim, J., Lee, Y., Roh, K., Kim, M.-S., & Kang, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.003 · Cited by 7
Palmer, A. K., Jensen, M. D., Tchkonia, T., & Kirkland, J. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00009-2 · Cited by 9
Wang, Y., Ren, X., Huang, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1082293 · Cited by 7
“The bias risk of all the enrolled RCTs was assessed by two authors (Yangyang Wang and Xiyang Ren) using the Cochrane Risk of Bias Tool, involving seven items: random sequence generation, allocation sequence concealment, blinding of population and personnel, blinding of outcome evaluation, incomplete outcome data, sele…”
MethodKitaeva, K. V., Solovyeva, V. V., Blatt, N. L., & Rizvanov, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010643 · Cited by 7
“…senescent cells exhibit increased β -galactosidase activity (referred to as senescence-associated β -galactosidase, SA-β -gal is one of the widely used markers of aged cells) at pH 6.0, activation of signaling pathways, and secretion of various growth factors, chemokines, and cytokines [35].”
BackgroundInfluentialA Review of the Repair of DNA Double Strand Breaks in the Development of Oral Cancer
Prime, S. S., Darski, P., Hunter, K. D., Cirillo, N., & Parkinson, E. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074092 · Cited by 11
“In the skin, the primary cell type that expresses senescent markers are ageing melanocytes, but the senescence spreads to neighboring keratinocytes by paracrine mechanisms [27], which in turn, results in a decrease in tissue proliferation [28,29].”
BackgroundContributions of Telomere Biology to Human Age-Related Disease
Yang, T.-L., Song, S., & Johnson, F. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00007-1 · Cited by 11
Merolle, M., Mongiardi, M. P., Piras, M., Levi, A., & Falchetti, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041490 · Cited by 8
“Through the activity of SASP, senescent cells may either promote [16] or suppress [17] cancer growth in a non-cell-autonomous way.”
BackgroundBreathe it in – Spotlight on senescence and regeneration in the lung
Majewska, J., & Krizhanovsky, V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111550 · Cited by 7
Senotherapeutic Drugs: A New Avenue for Skincare?
Lee, B. P., & Harries, L. W. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008782 · Cited by 9
Impaired differentiation of small airway basal stem/progenitor cells in people living with HIV
Chung, N. P. Y., Khan, K. M. F., Andreoli, M., Kaner, R. J., O’Beirne, S. L., & Crystal, R. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-06373-7 · Cited by 8
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2
Ferrari, D., Rubini, M., & Burns, J. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904419 · Cited by 7
“Given involvement of the inflammasome in paracrine senescence (116) and purinergic P2Y14 receptor modulation of stress-induced hematopoietic progenitor cell senescence (117, 118), purinergic pathways may present new pharmacological avenues for controlling senescence-mediated morbidities from SARS-CoV-2 infection.”
BackgroundTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 11
Zirkel, A., Nikolić, M., Sofiadis, K., Mallm, J., Brant, L., Becker, C., Altmüller, J., Franzen, J., Koker, M., Gusmao, E. G., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/127522 · Cited by 5
“and paracrine signaling in the cell population (Acosta et al., 2013; Davalos et al., 2013; Hoare and Narita, 2016; Rodier et al., 2009) and leads to replicative arrest, and marked changes in gene expression, secretory activity, and chromatin structure (Ovadya and Krizhanovsky, 2014; Rai and”
BackgroundNLRP1 inflammasome modulates senescence and senescence-associated secretory phenotypePreprint
Muela‐Zarzuela, I., Suarez-Rivero, J. M., Gallardo-Orihuela, A., Wan, C., Izawa, K., de Gregorio-Procopio, M., Coillin, I., Ryffel, B., Kitaura, J., Sanz, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.06.527254 · Cited by 6
“Despite scientific advances in the biology of the NLRP1 and NLRP3 inflammasomes, the role that these proteins play in senescence remain controversial (6-9).”
BackgroundRecent Advances in Senotherapeutics Delivery
Choi, J. Y., Yee, S. F., Tchangalova, T., Yang, G., & Fisher, J. P. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0212 · Cited by 6
“3,4 A recent meta-analysis examined the association between endogenous level of cellular senescence in human tissue type and donor age.”
The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease
Torre, M., Zanella, C. A., & Feany, M. Β. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.013 · Cited by 8
Overview of molecular signatures of senescence and associated resources: pros and cons
Ntintas, O. A., Vagena, S., Pantelis, P., Theocharous, G., Petty, R., Evangelou, K., & Gorgoulis, V. G. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70134 · Cited by 6
Tendon Tissue Engineering: Pathophysiological Mechanism and Bioengineering Therapy of Tendinopathy
Chen, B., Zhao, Y., Guo, S., Tang, C., Xu, B., Zhou, M., Chen, Q., Ma, L., Lyu, J., Guo, L., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s550439 · Cited by 8
“108 SASP also promotes chronic inflammation, induces inflammatory infiltration of tendons and leads to senescence of immune cells, which diminishes the body’s ability to regulate inflammation and clear senescent cells.”
Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation
Qoura, L. A., Churov, A. V., Maltseva, O. N., Ерусланова, К. А., & Zeng, G. (2026) · Biogerontology · doi:10.1007/s10522-026-10449-6 · Cited by 12
“Reciprocal paracrine signaling among such cells establishes a self-reinforcing inflammatory niche that promotes lipid retention (Acosta et al. 2013), extra-cellular matrix remodeling (Freitas-Rodríguez et al. 2017; Sun et al. 2022), and fibrous cap destabilization (Wang et al. 2015).”
Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells
Xie, X., Zhu, H., Li, Y., Chen, D., & Fan, T. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1731054 · Cited by 6
“Contrastly, senescence is the basically irreversible stagnation of growth that occurs when cells are damaged by potential carcinogens [16].”
BackgroundRadiation and Diabetic Retinopathy: A Dark Synergy
Gardiner, T. A., ARCHER, D. B., Silvestri, G., & Amoaku, W. M. K. (2023) · International Journal of Translational Medicine · doi:10.3390/ijtm3010011 · Cited by 6
Rahimpour, S., Clary, B. L., Nasoohi, S., Berhanu, Y. S., & Brown, C. M. (2024) · Aging and Disease · doi:10.14336/ad.2024.1293 · Cited by 28
“This lack of AMPK activation allows NF-kB to have an unimpeded pro-inflammatory response and increased cell survival, resulting in increased inflammatory conditions [24, 25].”
Xu, Y., You, J., Yao, J., Hou, B., Wang, W., & Hao, Z. (2025) · Urolithiasis · doi:10.1007/s00240-025-01734-z · Cited by 14
“Additional contributors include endoplasmic reticu - lum stress and the subsequent unfolded protein response, which collectively participate in ROS production under various physiological and pathological conditions [48].”
Burke, A. J., McAuliffe, J. D., Natoni, A., Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.07.005 · Cited by 14
Molecular therapies delaying cardiovascular aging: disease- or health-oriented approaches
Magenta, A., Lorde, R., Syed, S. B., Capogrossi, M. C., Puca, A. A., & Madeddu, P. R. (2020) · Vascular Biology · doi:10.1530/vb-19-0029 · Cited by 6
Targeting senescent cell clearance: An approach to delay aging and age-associated disorders
Qiu, Z., Jia, J., Zou, H., Ao, Y., Liu, B., & Wang, Z. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.12.001 · Cited by 7
The role of senescence-associated secretory phenotype (SASP) in cellular senescene
Lime, F. V. I. D., & Hardiany, N. S. (2021) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.33 · Cited by 7
“The binding of signal molecules in several types of cells, including senescence cells, can activate these receptors and trigger important intracellular signaling pathways, such as the mitogen-activated protein kinase (MAPK), Janus kinase (JAK)-signal transducer and activator of transcription (STAT), and NF-κB pathway…”
BackgroundDai, L., Wang, X., Bai, T., Liu, J., Chen, B., Li, T., & Yang, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.961554 · Cited by 7
“Cellular senescence has been revealed to inhibit the progression of colon cancer cells (Acosta et al., 2013; Cho et al., 2013).”
BackgroundMarodin, M. S. J., de Godoy, J. A. P., Alves‐Paiva, R. M., Alvarez, K. C. A., Mitsugi, T., Krepischi, A. C. V., Hamerschlak, N., Bortolini, M. A. T., Castro, R. A., Kondo, A. T., et al. (2022) · Stem Cells International · doi:10.1155/2022/1613636 · Cited by 8
“Also, senescent cells have the potential to stimulate the senescence of neighboring healthy cells by secretion of soluble factors such as TGF-β [28].”
BackgroundOdeh, A., Eddini, H., Shawasha, L., Chaban, A., Avivi, A., Shams, I., & Manov, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065132 · Cited by 7
“Cellular senescence is accompanied by the secretion of various molecules such as cytokines, chemokines, growth factors, matrix metalloproteinases (MMPs), collectively referred to as the senescence-associated secretory phenotype (SASP) [3,4].”
BackgroundYang, J., Yang, N., Zhao, H., Qiao, Y., Li, Y., Wang, C., Lim, K., Zhang, C., Yang, W., & Lu, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03463-9 · Cited by 7
“It was reported that in SVZ of diabetes mice excessive adipose deposition was observed and neurogenesis was impaired accompanied by elevated in ammatory cytokines in the bloodstream [1, 28].”
BackgroundWong, L. P., Alias, H., Tan, K. M., Wong, P., Murugan, D. D., Hu, Z., & Lin, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1254470 · Cited by 6
SIN3B, the SASP, and pancreatic cancer
Cantor, D. J., & David, G. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969167 · Cited by 8
“Several groups have previously identified IL-1a as an upstream regulator of the SASP both in vitro and in vivo.(8,9) Moreover, Chia and colleagues recently described that oncogenic KRas induces IL-1a expression in PDAC, which in turn stimulates NF-kb activity, previously described to be required for the SASP.”
BackgroundNutritional Modulators of Cellular Senescence In Vitro
Provinciali, M., Pierpaoli, E., Piacenza, F., Giacconi, R., Costarelli, L., Basso, A., Recchioni, R., Marcheselli, F., Bray, D. H., Benlhassan, K., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00022-4 · Cited by 8
Senescence Phenotypes Induced by Ras in Primary Cells
Lau, L., & David, G. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_2 · Cited by 7
Measuring the Inflammasome in Oncogene-Induced Senescence
Fernández-Duran, I., Tarrats, N., Hari, P., & Acosta, J. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_7 · Cited by 7
Self-citationProteomics Approaches to Define Senescence Heterogeneity and Chemotherapy Response
Petit, C., Guillon, J., Toutain, B., Boissard, A., Patsouris, A., Lelièvre, E., Guette, C., & Coqueret, O. (2019) · PROTEOMICS · doi:10.1002/pmic.201800447 · Cited by 5
A Multidimensional Systems Biology Analysis of Cellular Senescence in Ageing and DiseasePreprint
Avelar, R. A., Ortega, J. G., Tăcutu, R., Tyler, E. J., Bennett, D. F., Binetti, P., Budovsky, A., Chatsirisupachai, K., Johnson, E., Murray, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/743781 · Cited by 6
“3 the surrounding extracellular matrix, and other structural components, resulting in chronic inflammation, the induction of senescence in healthy cells, and vulnerable tissue (Acosta et al., 2013; van Deursen, 2014).”
BackgroundA New Gene Set Identifies Senescent Cells and Predicts Senescence-Associated Pathways Across Tissues
(2021) · doi:10.21203/rs.3.rs-1034608/v1 · Cited by 6
Senescence as a therapeutic target
Meyer, K. R., Lopez-Dominguez, J. A., Maus, M., Kovatcheva, M., & Serrano, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00014-6 · Cited by 6
Chandrasegaran, S., Sluka, J. P., & Shanley, D. P. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012298 · Cited by 10
“This result within the model simulations may be expected since paracrine senescence is associated with SASP rich in inflammatory and proteolytic components [28,72,73,80].”
Ligand-specific regulation of a binary enhancer code dictating cellular senescence
Suter, T., Friedman, M. J., Tazearslan, C., Merkurjev, D., Ohgi, K., Meluzzi, D., Rosenfeld, M. G., & Suh, Y. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506321122 · Cited by 5
Tang, H., Zhang, X., Hu, S., Song, Y., Jin, W., Zou, J., Zhang, Y., Guo, J., An, P., Luo, J., et al. (2025) · Targets · doi:10.3390/targets3030023 · Cited by 13
“Transferring senescent T cells into middle-aged mice aggravates angiotensin-induced cardiovascular damage [41].”
Mei, J., Schäfer, N., Wei, P., Kong, Z., Li, S., Pann, P., Ehrnsperger, M., Johnstone, B., Matalová, E., & Grässel, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1677801 · Cited by 9
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
Atkinson, J., Dokiburra, A., Groover, H., Godbout, J. P., Segal, B. M., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1681724 · Cited by 6
Senotherapeutics for metabolic disease and diabetic complications
Palmer, A. K., Spinelli, R., Prata, L. G. P. L., Chaib, S., Suda, M., Tchkonia, T., Smith, U., & Kirkland, J. L. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70039 · Cited by 8
“1) [14–18].”
Ho, C. Z., Deng, L., Picone, R., Abderazzaq, F. O., Flanagan, N., Chua, D. Z., Low, B. C., & Wu, S. K. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-10-0445 · Cited by 7
The impact of cellular senescence on aging skeletal muscle
Kamal, M. J., Bevington, R. T., Johnson, A., & Parise, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1719279 · Cited by 8
“Importantly, senescent cells are also capable of metabolically reprogramming adjacent, non-senescent cells through the actions of the SASP (discussed further below) (Acosta et al., 2013).”
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.